Articles from Invizyne Technologies, Inc.
Invizyne Technologies Selected for $2 Million Project to Advance Sustainable Aviation Fuel Capabilities
Project is part of the U.S. Department of Defense’s BioMADE initiative to support U.S. bioindustrial manufacturing innovations and workforce development
By Invizyne Technologies, Inc. · Via GlobeNewswire · November 19, 2024
Invizyne Technologies Announces Closing of Initial Public Offering
Monrovia, CA, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and chemicals for everyday life, today announced the closing of its initial public offering of 1,875,000 shares of its common stock at a public offering price of $8.00 per share. The shares began trading on NASDAQ under the ticker symbol “IZTC” on November 13, 2024.
By Invizyne Technologies, Inc. · Via GlobeNewswire · November 14, 2024
Invizyne’s Nasdaq IPO Marks New Era of Biomanufacturing
Underlying technology demonstrates the use of enhanced enzyme systems outside of cells can bypass many of the limitations associated with traditional cell-based synthetic biology
By Invizyne Technologies, Inc. · Via GlobeNewswire · November 13, 2024
Invizyne Technologies Begins Trading on NASDAQ
Next Generation Synthetic Biology Company Will Trade Under Ticker Symbol "IZTC"
By Invizyne Technologies, Inc. · Via GlobeNewswire · November 13, 2024
Invizyne Technologies to Begin Trading on NASDAQ on November 13, 2024
Next Generation Synthetic Biology Company Will Trade Under Ticker Symbol "IZTC"
By Invizyne Technologies, Inc. · Via GlobeNewswire · November 12, 2024
Invizyne Technologies Announces Pricing of $15 Million Initial Public Offering
Shares to Begin Trading on NASDAQ on November 12, 2024, Under the Ticker Symbol “IZTC”
By Invizyne Technologies, Inc. · Via GlobeNewswire · November 11, 2024
Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
By Invizyne Technologies, Inc. · Via GlobeNewswire · May 7, 2024
Invizyne Technologies Announces Filing of Registration Statement for Proposed Offering and Listing on Nasdaq
Monrovia, CA, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of enzyme-based biomanufacturing systems – and a subsidiary of MDB Capital Holdings, LLC, (NASDAQMDBH) ("MDB") – today announced it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") for the sale of its common stock in a firm commitment public offering.
By Invizyne Technologies, Inc. · Via GlobeNewswire · February 12, 2024
Michael Burns Joins Invizyne as Executive Vice President of Energy Transition
Monrovia, CA, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of enzyme-based biomanufacturing systems – and a subsidiary of MDB Capital Holdings, LLC, (NASDAQMDBH) ("MDB") – today announced the appointment of Michael Burns to its senior leadership team as Executive Vice President, Energy Transition.
By Invizyne Technologies, Inc. · Via GlobeNewswire · November 8, 2023
Invizyne Selected by Shell GameChanger Accelerator Powered by NREL for Sixth Cohort
Non-Dilutive Funding and Resources Provided to De-Risk Investment and Accelerate Commercialization
By Invizyne Technologies, Inc. · Via GlobeNewswire · October 17, 2023
Invizyne Awarded Additional $3.77 Million Grant from U.S. Department of Energy
Funding Supports Project to Optimize and Scale Up Isobutanol Production to Address Potential $27.4 Billion Sustainable Aviation Fuel Market
By Invizyne Technologies, Inc. · Via GlobeNewswire · October 11, 2023